Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Sarepta seeks to expand Duchenne gene therapy Elevidys use to toddlers
2 weeks ago
R&D
Deputy FDA chief mulls shaking up PDUFA reauthorization structure
2 weeks ago
FDA poses efficacy, safety questions over four cancer drugs ahead of two-day adcomm
2 weeks ago
Pharma
RFK Jr. adopts new chikungunya vaccine guidance; other recommendations remain under review
3 weeks ago
R&D
Pharma
New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says
3 weeks ago
Pharma
FDA warns Mayne Pharma over 'misleading' presentation slides on birth control pill
3 weeks ago
Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision
3 weeks ago
Pharma
RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings
3 weeks ago
Pharma
RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees
3 weeks ago
Pharma
FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer
3 weeks ago
Pharma
GSK awaits Nucala decision after FDA target date passes
4 weeks ago
Pharma
FDA grants Verastem first approval for rare ovarian cancer treatment
4 weeks ago
Pharma
FDA will convene vaccine advisors to discuss Covid strain updates
4 weeks ago
Pharma
FDA's ODAC will review drugs for four different cancers at meeting in May
4 weeks ago
Pharma
What Vinay Prasad means for CBER, vaccines, drug approvals and more
4 weeks ago
Pharma
Sarepta’s stock plummets after Prasad appointment, low Elevidys sales
4 weeks ago
Pharma
Trump, FDA zero in on foreign factories to give domestic sites an edge
4 weeks ago
Pharma
Manufacturing
FDA picks controversial doctor Vinay Prasad as CBER director, in about-face from Marks
4 weeks ago
New opioid data may not be generalizable, FDA adcomm says
4 weeks ago
Pharma
FDA adcomm will review Capricor's cell therapy for Duchenne muscular dystrophy
4 weeks ago
Pharma
Cell/Gene Tx
Even as questions grow over RFK Jr.'s vaccine policy, BioNTech doesn't see ‘near-term’ impact
4 weeks ago
R&D
Pharma
Post-Hoc: The big question for the FDA after Stealth’s PDUFA delay
4 weeks ago
Exclusive: After FDA firings, drug reviewers are asked to volunteer for administrative work
4 weeks ago
White House budget request would cut billions at NIH and CDC, add $500M for MAHA
4 weeks ago
Pharma
First page
Previous page
1
2
3
4
5
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit